Prediction of Long-term Kidney Failure in Renal Transplant With Chronic Allograft Dysfunction Using Stage-Specific Hazard Rates
| dc.contributor.author | Khalkhali, Hamid Reza | |
| dc.contributor.author | Ghafari, Ali | |
| dc.date.accessioned | 2026-04-06T11:16:12Z | |
| dc.date.issued | 2012-02 | |
| dc.description.abstract | Objectives: The process of kidney failure in renal transplant recipients with chronic allograft dysfunction is characterized by a progressive decline in glomerular filtration rate over time that it is determined by the 5-stage model. This study used stage-based statistical survival analysis to predict graft survival in renal transplant recipients with chronic allograft dysfunction. Materials and Methods: In a single-center, retrospective study, 214 renal transplant recipients with chronic allograft dysfunction were investigated at a university hospital in Iran from 1997 to 2005. At each patient visit, kidney function was assessed using glomerular filtration rate and stage of disease. Results: The estimated stage-specific hazard rates of disease progression are stage one, 453.936; stage two, 485.040; stage three, 545.808; and stage four; 649.488 per 1000 person-years. The estimated mean times in each stage were as follows: kidney damage with normal or increased glomerular filtration rate, 26.43 months; kidney damage with mildly decreased glomerular filtration rate, 24.74 months; moderate kidney disease, 21.98 months; and severe kidney disease; 18.48 months. These estimates yield a mean time from stage 1 to kidney failure of 91.63 months. The probability of graft survival was predicted using estimated stage-specific hazard rates. The 18th, 58th, 118th, and 155th months’ death-censored graft survival probabilities were 0.99, 0.75, 0.25, and 0.10. Conclusions: In this method of survival analysis, we can determine a statistical model according to a real clinical model in renal transplant recipients with chronic allograft dysfunction. It enables us to determine the stage-specific hazard rates of disease progression. These findings can help nephrologists to understand the kidney disease process and better predict graft survival. | |
| dc.identifier.citation | Experimental and Clinical Transplantation, Cilt, 10, Sayı, 1, 2012 ss. 8-13 | en |
| dc.identifier.eissn | 2146-8427 | en |
| dc.identifier.issn | 1304-0855 | |
| dc.identifier.issue | 1 | en |
| dc.identifier.uri | https://hdl.handle.net/11727/14797 | |
| dc.identifier.volume | 10 | en |
| dc.language.iso | en | |
| dc.publisher | Başkent Üniversitesi | |
| dc.source | Experimental and Clinical Transplantation | en |
| dc.subject | Graft survival | |
| dc.subject | 5-stage model | |
| dc.subject | Phase-type distribution | |
| dc.subject | Markov model | |
| dc.subject | Survival analysis | |
| dc.title | Prediction of Long-term Kidney Failure in Renal Transplant With Chronic Allograft Dysfunction Using Stage-Specific Hazard Rates | |
| dc.type | Article |